# Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis

> **NCT06951776** · NA · NOT_YET_RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 28 (estimated)

## Conditions studied

- Circadian Rhythm Disorders
- Osteoporosis

## Interventions

- **BEHAVIORAL:** Morning administration group of teriparatide
- **BEHAVIORAL:** Evening administration group of teriparatide

## Key facts

- **NCT ID:** NCT06951776
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06951776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06951776, "Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06951776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*